Evogene's Sales, Loss Rise in Q1

The plant gene discovery technology company boosted its R&D spending in the first quarter and it took a loss on revaluation expenses from its 2007 IPO.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories